Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 47-3238441 · Snapshot of IRS recognition, filing currency, financial health, and governance.
To find treatments and a cure for the rare cancer, epithelioid hemangioendothelioma (ehe), by advancing research and driving collaboration between patients, researchers, and clinicians.
Total Revenue
$585K
FY2024
Total Expenses
$814K
FY2024
Net Assets
$1.5M
Program Ratio
88.6%
expenses on programs
Employees
2
Volunteers
16
Board Members
6
Voting
6
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.